Science Explorer Back to mapMap
Discussion
Topic · Epidemiology

Chronic Disease Management Strategies

Chronic Disease Management Strategies is a research topic within Epidemiology. Science Explorer counts 34k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, implications, and management of multimorbidity, particularly in older adults. It explores the prevalence, impact on healthcare utilization, quality of life, and the challenges faced in providing care for individuals with multiple chronic conditions in primary care settings. The papers also discuss the development and adaptation of clinical guidelines, as well as the need for patient-centered approaches to address the complex needs associated with multimorbidity.

  • Multimorbidity
  • Chronic Conditions
  • Healthcare Utilization
  • Quality of Life
  • Primary Care
  • Comorbidity
  • Epidemiology
  • Health Services
  • Patient Complexity
  • Clinical Practice Guidelines
Research works
34k
fractional, since 1950
In the world top 10%
3.4k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+17%
the tick is no change
Largest producer
United States
31% of the 10 largest, 2022-now
Chronic Disease Management Strategies

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Chronic Disease Management Strategies research?

By volume, the United States and China publish the most (2.2k and 1.4k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.2k works
  2. 2 China 1.4k works
  3. 3 United Kingdom 1.1k works
  4. 4 India 400 works
  5. 5 Canada 368 works
  6. 6 Spain 356 works
  7. 7 Australia 332 works
  8. 8 Germany 311 works
  9. 9 Netherlands 242 works
  10. 10 Japan 230 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 31.3%China: 20.4%United Kingdom: 16.2%India: 5.7%6 others listed: 26.4%31%largest
United States2,184 · 31.3%China1,425 · 20.4%United Kingdom1,133 · 16.2%India400 · 5.7%6 others listed1,840 · 26.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Chronic Disease Management Strategies research?

By volume in 2022-now, Harvard University publishes the most Chronic Disease Management Strategies research, followed by Peking University and United States Department of Veterans Affairs.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 86 works
  2. 2 Peking UniversityChina 59 works
  3. 3 United States Department of Veterans AffairsUnited States 56 works
  4. 4 University of North Carolina at Chapel HillUnited States 55 works
  5. 5 Johns Hopkins UniversityUnited States 51 works
  6. 6 University of TorontoCanada 50 works
  7. 7 University College LondonUnited Kingdom 50 works
  8. 8 Sichuan UniversityChina 44 works
  9. 9 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 41 works
  10. 10 King's College LondonUnited Kingdom 38 works

Who are the leading researchers in Chronic Disease Management Strategies?

The most-cited researchers publishing on Chronic Disease Management Strategies include Ahmedin Jemal, Christopher J L Murray and Simon Iain Hay.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Christopher J L Murray United States 583k citations
  3. 3 Simon Iain Hay United States 452k citations
  4. 4 Theo Vos United States 439k citations
  5. 5 George Davey Smith United Kingdom 435k citations
  6. 6 Ali H. Mokdad United States 429k citations
  7. 7 Walter Churchill Willett United States 411k citations
  8. 8 Mark J. Daly United States 403k citations
  9. 9 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  10. 10 Ronald C. Kessler United States 360k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Chronic Disease Management Strategies?

The most cited paper in Chronic Disease Management Strategies is "A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation" (Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al., 1987), with 50,676 citations. Next come "Frailty in Older Adults: Evidence for a Phenotype" (25,162) and "Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017" (14,263).

Most cited papers
#PaperReleasedCitations
1 A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation Mary E. Charlson, Peter Pompei, Kathy L. Aleš et al. · Journal of Chronic Diseases 1987 50,676
2 Frailty in Older Adults: Evidence for a Phenotype Linda P. Fried, Catherine M. Tangen, Jeremy D Walston et al. · The Journals of Gerontology Series A Mar 2001 25,162
3 Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 Spencer Lewis James et al. · The Lancet Open access990 authors Nov 2018 14,263
4 Coding Algorithms for Defining Comorbidities in ICD-9-CM and ICD-10 Administrative Data Hude Quan, Vijaya Sundararajan, Patricia Halfon et al. · Medical Care 13 Oct 2005 10,878
5 Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases Richard A. Deyo · Journal of Clinical Epidemiology Jun 1992 10,573
All 99 most cited papers, with filters and sorting

Where is Chronic Disease Management Strategies research done?

The largest centres of Chronic Disease Management Strategies research in 2022-now are London (United Kingdom), Beijing (China), New York (United States) and Singapore (Singapore). Among places with at least 20 works in it, it is an unusually large share of all research in Leicester and Odense.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 320 works
  2. 2 BeijingChina 233 works
  3. 3 New YorkUnited States 108 works
  4. 4 SingaporeSingapore 99 works
  5. 5 SeoulSouth Korea 94 works
  6. 6 GuangzhouChina 93 works
  7. 7 BostonUnited States 89 works
  8. 8 ShanghaiChina 88 works
  9. 9 MadridSpain 79 works
  10. 10 BarcelonaSpain 79 works

Where it is the local speciality

  1. LeicesterGB · 36.9 works7.7×
  2. OdenseDK · 28.2 works6.5×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Chronic Disease Management Strategies than the world average.

See Chronic Disease Management Strategies on the map

Where is the best place to study Chronic Disease Management Strategies?

Among universities, judged by research, Harvard University, International Institute for Population Sciences and Sichuan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.87%fractional works in this field (log) →share of work in the world top 10% →International Instit…Sichuan UniversityPeking UniversityHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 68.615.2%3.0×86 +8.9%
2International Institute for Population SciencesIndia 67.929.9%57.7×17 +138.5%
3Sichuan UniversityChina 67.626.2%2.1×44 +111.2%
4Peking UniversityChina 66.220.2%3.2×59 +126.7%
5London School of Hygiene & Tropical MedicineUnited Kingdom 61.719.9%12.1×17 +14.7%
6Imperial College LondonUnited Kingdom 59.716.0%3.8×35 +22.5%
7Johns Hopkins UniversityUnited States 58.512.1%3.6×51 +9.7%
8Karolinska InstitutetSweden 58.112.9%6.8×35 +10.2%
9Capital Medical UniversityChina 58.019.5%3.9×38 +112.4%
10University of OxfordUnited Kingdom 57.816.8%2.6×34 +30.3%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Chronic Disease Management Strategies, country by country

Is Chronic Disease Management Strategies research growing?

Output in 2022-2025 was 17% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Chronic Disease Management Strategies.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Chronic Disease Management Strategies as a percentage of every work published that year, 0.040% in 2024.

still counting0.020%0.040%0.060%Chronic Disease Management Strategies0.046% in 202519801990200020102020

Fractional works of Chronic Disease Management Strategies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Chronic Disease Management Strategies10.1% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Chronic Disease Management Strategies. Posts are plain text and can be reported.